CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Treatment of Genotype 1 HCV Treatment-Naïve Patients: final results of phase III study ADVANCE
DOI 10.1055/s-0030-1269659
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Berg, P Buggisch, P Malinski, H Diepolder, S Mauss, J Rasenack, T Goeser, WE Schmidt, R Kauffman, M Beumont-Mauviel, S Decker-Burgard, S Zeuzem
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
ADVANCE study is a 3-arm double-blind, randomized, placebo-controlled Phase 3 study assessing efficacy and safety of two telaprevir (T)-based response-guided regimens compared with peginterferon alfa-2a 180µg/week and ribavirin 1000–1200mg/day (PR) in treatment-naïve patients (pts) with chronic genotype 1 HCV infection. Methods: Treatment arms wereT 750mg q8h in combination with PR for 8 weeks, followed by additiona…
Zitieren
Zitierempfehlung
T Berg, P Buggisch, P Malinski, H Diepolder, S Mauss, J Rasenack, T Goeser, WE Schmidt, R Kauffman, M Beumont-Mauviel, S Decker-Burgard, S Zeuzem (2011) Treatment of Genotype 1 HCV Treatment-Naïve Patients: final results of phase III study ADVANCE. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0030-1269659
Mit CareLit weiterarbeiten